Literature DB >> 2780259

Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs.

P E Hicks1, D Martin, D Dumez, E Zazzi-Sudriez, J M Armstrong.   

Abstract

1) CROM reduced hypoxia-induced pulmonary vasoconstriction and maintained PaO2 with an increase in cardiac output. 2) Low doses of CROM infused into the kidney caused pronounced renal vasodilation, marked natriuresis and a significant increase in cardiac output with minor changes in blood pressure. In addition to its previously described systemic antihypertensive effects, CROM also reduces hypoxia-induced pulmonary hypertension and shows marked renal vasodilation with natriuresis in anaesthetized dogs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780259     DOI: 10.1007/BF00582302

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  3 in total

1.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

2.  BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.

Authors:  R E Buckingham; J C Clapham; T C Hamilton; S D Longman; J Norton; R H Poyser
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

3.  Estimation of effective pulmonary capillary pressure in intact lungs.

Authors:  H Holloway; M Perry; J Downey; J Parker; A Taylor
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-03
  3 in total
  1 in total

Review 1.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.